(Q43034046)

12 November 2017

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system (English)

1 reference

12 November 2017

1 reference

1 reference

7

1 reference

12 November 2017

Muriel Lavie

1

0 references

Cécile Voisset

series ordinal

2

object named as

Cécile Voisset

1 reference

12 November 2017

6

Czeslaw Wychowski

1 reference

12 November 2017

3

Ngoc Vu-Dac

1 reference

12 November 2017

5

Gilles Duverlie

1 reference

12 November 2017

Virginie Zurawski

4

1 reference

PubMed ID

17133472

12 November 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

12 November 2017

1 reference

12 November 2017

44

1 reference

12 November 2017

6

1 reference

12 November 2017

1626-1634

1 reference

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

12 November 2017

1 reference

7 January 2021

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

1 reference

7 January 2021

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

7 January 2021

Complete replication of hepatitis C virus in cell culture

1 reference

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

7 January 2021

Robust hepatitis C virus infection in vitro

1 reference

7 January 2021

Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids

1 reference

7 January 2021

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

7 January 2021

Hepatitis C virus entry: potential receptors and their biological functions

1 reference

7 January 2021

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

1 reference

7 January 2021

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

1 reference

7 January 2021

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

1 reference

7 January 2021

Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases

1 reference

7 January 2021

Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake

1 reference

7 January 2021

Serum amyloid A, the major vertebrate acute-phase reactant

1 reference

7 January 2021

Characterization of functional hepatitis C virus envelope glycoproteins.

1 reference

7 January 2021

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

1 reference

7 January 2021

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

1 reference

7 January 2021

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

1 reference

7 January 2021

Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I.

1 reference

7 January 2021

Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.

1 reference

7 January 2021

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins

1 reference

7 January 2021

TaqMan amplification system with an internal positive control for HCV RNA quantitation

1 reference

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

7 January 2021

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

1 reference

7 January 2021

Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria

1 reference

7 January 2021

Serum amyloid A is an innate immune opsonin for Gram-negative bacteria

1 reference

7 January 2021

A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21406

1 reference

12 November 2017

1 reference

PubMed ID

17133472